Anti-TNF–refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab
- DOI
- 10.1007/s12328-026-02394-1
- Published
- 2026-09-22
- Container
- Clinical Journal of Gastroenterology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12328-026-02394-1,
title = {Anti-TNF–refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab},
author = {Natsuki Ito and Takahiro Kudo and Hidetaka Eguchi and Keisuke Jimbo and Yasushi Okazaki and Toshiaki Shimizu and Hiromichi Shoji},
year = {2026},
journal = {Clinical Journal of Gastroenterology},
doi = {10.1007/s12328-026-02394-1},
url = {https://doi.org/10.1007/s12328-026-02394-1}
}RIS
TY - JOUR TI - Anti-TNF–refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab AU - Natsuki Ito AU - Takahiro Kudo AU - Hidetaka Eguchi AU - Keisuke Jimbo AU - Yasushi Okazaki AU - Toshiaki Shimizu AU - Hiromichi Shoji PY - 2026 JO - Clinical Journal of Gastroenterology DO - 10.1007/s12328-026-02394-1 UR - https://doi.org/10.1007/s12328-026-02394-1 ER -
APA
Ito, N., Kudo, T., Eguchi, H., Jimbo, K., Okazaki, Y., Shimizu, T., & Shoji, H. (2026). Anti-TNF–refractory inflammatory bowel disease associated with a novel XIAP frameshift variant successfully treated with ustekinumab. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02394-1
Source records
- crossref · retrieved 2026-09-25T15:51:12.293Z